Skip to content
lifestyle.theglimpse.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Breye Therapeutics
Breye Therapeutics raises €67.5 million in over-subscribed Series A financing
September 29, 2026
Breye Therapeutics has a paper on its oral danegaptide treatment for patients with NPDR published in Science Translational Medicine
September 23, 2026
Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium
February 12, 2026